7
Apr
2026
Computation, Chemistry & Culture For Drug Discovery: Abbas Kazimi on The Long Run
Abbas Kazimi is today’s guest on The Long Run. Abbas is the CEO of Boston-based Nimbus Therapeutics. It’s a privately held company that discovers and develops oral small molecule drugs. It does this through a combination of computational chemistry, medicinal chemistry, AI, and the combined effort of a small group of talented and hardworking people. Nimbus is probably best known... Read More